CLIVI

High-Level Overview

Clivi is Mexico's first digital diabetes clinic, providing a technology-driven platform for comprehensive type 2 diabetes management.[2][3][4][5] It serves patients in Latin America by connecting them with endocrinologists, nutritionists, and psychologists via accessible channels like WhatsApp, while supplying glucometers, test strips, blood testing kits, and medication.[2][3][4] The platform solves critical access gaps—one endocrinologist per nearly 10,000 patients in Mexico—using AI for personalized monitoring and treatment plans, achieving 94% diabetes control within six months for thousands of users.[2][3] With $2 million in annual recurring revenue and 2,000 new patients monthly as of mid-2023, Clivi raised $10 million in seed funding in 2023 and targets 1 million patients across Latin America in five years.[3][4]

Origin Story

Founded in 2021 by Ricardo Moguel (CEO), Kyle, and Bruno, Clivi emerged from personal tragedy: two family friends died from diabetes complications due to inadequate treatment.[4] Targeting Latin America's 40 million diabetes cases—Mexico ranking sixth globally—the team built a digital clinic to optimize scarce medical capacity via phone-based distribution.[2][3][4] Early traction was rapid: live since October 2021, it became Mexico's second-largest private diabetes clinic in under a year by leveraging WhatsApp for direct patient access and feedback-driven improvements.[3][4]

Core Differentiators

• Hybrid Human-Tech Model: Balances AI automation with live expert care, enabling doctors to manage 300+ patients each (up to 800 per endocrinologist) through workflow tools and integrations.[3][4]
• Convenience and Affordability: Delivers full-service kits (hardware, strips, meds) via subscriptions; accessible on WhatsApp, bypassing traditional barriers for underserved patients.[2][3][4]
• Proven Outcomes and Scalability: 94% control rate in six months; AI-enhanced platform automates functions to boost doctor capacity and expand to enterprises/public health.[2][3]
• Patient-Centric Iteration: Direct-to-consumer sales allow real-time feedback, creating a sticky experience for lifelong use in a market lacking comparable quality.[4][5]

(Note: A separate gaming-focused "Clivi" in Madrid exists but lacks the diabetes firm's prominence or funding[1]; this profile centers the healthtech leader.)

Role in the Broader Tech Landscape

Clivi rides the digital health boom, projected to hit $1.5 trillion globally, amid rising diabetes cases (over 422 million worldwide, majority in low/middle-income regions like Latin America).[3] Timing aligns with mobile penetration enabling WhatsApp-based care, disrupting fragmented systems where diabetes kills (e.g., top cause for Mexican women).[2][4] Market forces favor it: chronic disease overload, doctor shortages, and post-pandemic telehealth normalization position Clivi to dominate Mexico then LatAm, influencing ecosystems by setting standards for AI-human hybrid clinics and B2B expansions.[3][4]

Quick Take & Future Outlook

Clivi is poised to claim No. 1 status in Mexico by automating more via AI, scaling to enterprises, and hitting 10x revenue growth.[3][4] Trends like AI diagnostics, remote monitoring, and LatAm's 1 billion-diabetes projection by 2030 will propel it toward its 1 million-patient goal.[2][3] Its influence may evolve into a chronic disease platform beyond diabetes, redefining accessible care and inspiring regional healthtech. This digital pioneer turns a massive health crisis into scalable opportunity, echoing Livongo's U.S. impact but tailored for emerging markets.[3]